Startups
NeuroPace is the developer and manufacturer of the RNS System, a proven treatment option for adults who have disabling seizures that are not controlled by medication. The RNS System is the only medical device that is smart enough to respond to what’s happening in the brain to stop seizures at their source.
Safety Information
The RNS® System is an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures who have undergone diagnostic testing that localized no more than 2 epileptogenic foci, are refractory to two or more antiepileptic medications, and currently have frequent and disabling seizures.
Please refer to the product labeling for a detailed disclosure of specific indications, contraindications, warnings, precautions and adverse events. Rx only.
Safety Information
The RNS® System is an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures who have undergone diagnostic testing that localized no more than 2 epileptogenic foci, are refractory to two or more antiepileptic medications, and currently have frequent and disabling seizures.
Please refer to the product labeling for a detailed disclosure of specific indications, contraindications, warnings, precautions and adverse events. Rx only.
Overview
Location
United States, California, Mountain View
Employees
51-200
Phone
(866) 726-3876
Total raised
$150.3M
Founded date
1999
Investors 6
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 6, 2021 | New Enterprise Associates | nea.com |
| UCLA Ventures | ventures.ucla.edu | |
| KCK Medtech | kckmedtech.com | |
| CRG | crglp.com | |
| OrbiMed | orbimed.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Aug 31, 2020 | Funding round | $67M | |
| Oct 24, 2017 | Funding round | $74M |
Mentions in press and media 25
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 27, 2025 | Couples Impacted by Epilepsy Come Together for Groundbreaking Relationship Retreat in Princeton, NJ | Couples impacted by epilepsy gathered at The Peacock Inn in Princeton, NJ, for Navigating Us: Connecting Through the Epilepsy Journey, a relationship-centered retreat hosted by Epilepsy Services of New Jersey. The two-day event offered guid... |
| Mar 5, 2024 | NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million | |
| Oct 12, 2022 | NeuroPace announces first patient implant in trial of neuromod treatment for epilepsy | The NeuroPace RNS system (Image from NeuroPace) NeuroPace (Nasdaq:NPCE) announced that the first patient received their implant in the Nautilus clinical study of its RNS system. The company’s Nautilus study evaluates the safety and efficacy... |
| Jan 12, 2022 | NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue | MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today announced its preliminary, unaudit... |
| Jan 12, 2022 | NeuroPace : Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue - Form 8-K | NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue Mountain View, Calif. - January 11, 2022 - NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of pe... |
| Dec 22, 2020 | Epileptic Seizures Aren’t Entirely Random. Discovery May Lead To Seizure Forecasting System | |
| Sep 4, 2020 | StartUPDATES: New developments from healthcare startups | Self-insured employers, including several Fortune 500 companies, leverage Carrum Health’s technology-powered COE platform to avoid variation in the cost and quality of surgery and to deliver a superior patient experience. The platform enabl... |
| Aug 31, 2020 | NeuroPace Raises $67M in Funding | NeuroPace, Inc., a Mountain View, Calif.-based medical technology company, raised $67m in funding. It included $33m of new equity capital and $34m from convertible debt provided by current investors from a prior funding round. The equity ro... |
| Aug 31, 2020 | NeuroPace Grabs $67M Funding | MOUNTAIN VIEW, CA, NeuroPace announced that it had raised $67 million in a funding round led by Accelmed Partners. >> Click here for more funding data on NeuroPace >> To export NeuroPace funding data to PDF and Excel, click ... |
Show more
Reviews 0
FAQ about NeuroPace
When was NeuroPace founded?
NeuroPace was founded in 1999.
How much funding has NeuroPace raised?
NeuroPace has raised $150.3M in total across 3 funding rounds.
What funding rounds has NeuroPace raised?
Parsers VC lists 3 funding rounds of NeuroPace, among them a funding round of $67M on Aug 31, 2020 and a funding round of $74M on Oct 24, 2017.
Who has invested in NeuroPace?
Parsers VC lists 6 investors of NeuroPace, among them New Enterprise Associates, UCLA Ventures and KCK Medtech.
What has the press written about NeuroPace?
Parsers VC has collected 25 articles mentioning NeuroPace, among them “Couples Impacted by Epilepsy Come Together for Groundbreaking Relationship Retreat in Princeton, NJ” (Oct 27, 2025) and “NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million” (Mar 5, 2024).
Is NeuroPace still active?
Yes, NeuroPace is active; its latest activity on Parsers VC dates from Jan 20, 2026.